Ralph Burroughs
Psychiatric/Mental Health · Gulfport, MSNPI 1760674949
Payments from drug & device makers
Across 203 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$276
- Alkermes, Inc.$230
- Axsome Therapeutics, Inc.$183
- Otsuka America Pharmaceutical, Inc.$160
- Neurocrine Biosciences, Inc.$158
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,531 in reported general payments places this provider in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 47 | $165,005 |
| IngrezzaValbenazine Tosylate | 12 | $109,458 |
| Abilify MaintenaAripiprazole | 31 | $88,431 |
| VraylarCariprazine Hcl | 26 | $37,553 |
| Rivastigmine | 78 | $10,737 |
| EliquisApixaban | 15 | $8,350 |
| Haloperidol Decanoate | 82 | $4,935 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 85 | $4,365 |
| Bupropion XlBupropion Hcl | 54 | $3,678 |
| Haloperidol | 126 | $3,585 |
| Clozapine | 58 | $3,573 |
| Memantine Hcl | 146 | $2,984 |
| Paliperidone ErPaliperidone | 26 | $2,931 |
| Divalproex Sodium ErDivalproex Sodium | 112 | $2,909 |
| Aripiprazole | 72 | $2,252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $50 | $165,00547 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $158 | $109,45812 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $160 | $88,43131 claims |
| AbbVieVraylar | $1,503 | $37,55326 claims |
| Almatica Pharma LLCSertraline Hcl | $39 | $1,264164 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Gulfport
- Desiree NormanGulfport$10K
- Tangular BarnesGulfport$9K
- Anita HallGulfport$8K
- Belinda HoldenGulfport$7K
- Chantal SullivanGulfport$7K
- Anne TuckerGulfport$5K
- Kari WilliamsGulfport$4K
- Jo DrennanGulfport$4K
- Elizabeth GarrigaGulfport$4K
- Ashley KarelVicksburg$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.